advanced search

INJECTION

THREE PHASES TO SUCCESS IN STERILE INJECTABLES TECHNOLOGY TRANSFER
INJECTION
Jennifer Quint
Pfizer CentreOne
THREE PHASES TO SUCCESS IN STERILE INJECTABLES TECHNOLOGY TRANSFER
Jennifer Quint offers insights into how to plan and execute technology transfer effectively, explaining Pfizer CentreOne’s three-phased approach that can successfully support this pivotal event in a drug product programme’s journey to commercialisation.
PRODUCT SHOWCASE: ZwickRoell – Comprehensive Automated Testing Solutions
INDUSTRIALISATION
Wolfgang Moersch
ZwickRoell
PRODUCT SHOWCASE: ZwickRoell – Comprehensive Automated Testing Solutions
ZwickRoell showcases its comprehensive automated testing solutions.
UNDERSTANDING YOUR PROCESS RELIABILITY: COMPLIANCE CONSIDERATIONS FOR EMERGENCY-USE DELIVERY SYSTEMS
INJECTION
Richard Motruk
Kymanox
UNDERSTANDING YOUR PROCESS RELIABILITY: COMPLIANCE CONSIDERATIONS FOR EMERGENCY-USE DELIVERY SYSTEMS
Richard Motruk and Nathan Blazei discuss the issues to be considered in light of the US FDA’s tightened reliability standards for emergency-use autoinjectors.
KEY CONSIDERATIONS FOR AN OPTIMAL EMERGENCY-USE AUTOINJECTOR
INJECTION
Dr Adam Stops
Stevanato Group
KEY CONSIDERATIONS FOR AN OPTIMAL EMERGENCY-USE AUTOINJECTOR
Adam Stops and William Fortina introduce Maverick, an emergency-use autoinjector, and discuss key considerations during the device design and development, for primary packaging and manufacturing and assembly.
HERE TODAY AND DEFINITELY NOT GONE TOMORROW: WHY SIMPLICITY AND EASE OF USE ARE THE KEY FOR A NEW GENERATION OF REUSABLE INJECTORS
INJECTION
Dr Kate Hudson-Farmer
Phillips Medisize
HERE TODAY AND DEFINITELY NOT GONE TOMORROW: WHY SIMPLICITY AND EASE OF USE ARE THE KEY FOR A NEW GENERATION OF REUSABLE INJECTORS
Kate Hudson-Farmer discusses how a new electronic reusable autoinjector – the Aria Smart Autoinjector from Phillips-Medisize – has been designed and user-tested to challenge the preconceived ease-of-use notions about electronic autoinjectors, in addition to addressing how macro trends and personal consumer subtleties could become increasingly important in creating a competitive position as devices seek to improve patient engagement.
GX INNOSAFE – GREATER PROTECTION AGAINST NEEDLESTICK INJURIES
PREFILLED SYRINGES
Dr Wenzel Novak
Gerresheimer
GX INNOSAFE – GREATER PROTECTION AGAINST NEEDLESTICK INJURIES
Wenzel Novak and Stefan Verheyden introduce Gx InnoSafe, a novel integrated passive needle safety system for preventing needlestick injuries and accidental reuse of syringes that minimises additional burden on healthcare workers during injection and can be integrated into existing pharmaceutical filling operations without the need for adaptation or conversion of processing lines.
A NEW MINDSET FOR COMBINATION PRODUCT DEVELOPMENT
INJECTION
Asmita Khanolkar
SMC Ltd
A NEW MINDSET FOR COMBINATION PRODUCT DEVELOPMENT
Asmita Khanolkar outlines the latest trends in combination product development to overcome some of the current challenges of high dose/viscosity/volume delivery.
AIDAPTUS<sup>®</sup>: OWEN MUMFORD INTRODUCES ITS NEXT-GENERATION PLATFORM AUTOINJECTOR
INJECTION
Michael Earl
Owen Mumford
AIDAPTUS®: OWEN MUMFORD INTRODUCES ITS NEXT-GENERATION PLATFORM AUTOINJECTOR
Michael Earl introduces the next-generation Aidaptus® autoinjector, explaining how this latest platform device from Owen Mumford can contribute to a faster speed-to-market, increased flexibility during drug development and improved patient outcomes.
INTERVIEW WITH STEPHEN M PERRY AND NICHOLAS CICCARELLI
INTERVIEW
Stephen Perry
Kymanox
INTERVIEW WITH STEPHEN M PERRY AND NICHOLAS CICCARELLI
Stephen Perry and Nicholas Ciccarelli discuss the August 2021 acquisition of Neuma by Kymanox, highlighting how the acquisition has positioned Kymanox to lead the development of particularly complex drug delivery systems and cutting-edge medical device technologies, providing additional services to progress combination products to market.
PHOTOSTABILITY TESTS OF ANTIBODY DRUGS
PREFILLED SYRINGES
Yoshiko Sakuma
Mitsubishi Gas Chemical
PHOTOSTABILITY TESTS OF ANTIBODY DRUGS
Yoshiko Sakuma and Tomohiro Suzuki provide an overview of Mitsubishi Gas Chemical's OXYCAPT multilayer vial and syringe, with a particular focus on the recent investigations into the interaction of OXYCAPT’s UV barrier with the photostability of antibody drugs, compared with standard cyclo-olefin polymer and Type 1 glass.
YPSODOSE – SIMPLIFYING LARGE-VOLUME PATCH INJECTIONS
WEARABLES
Ian Thompson
Ypsomed
YPSODOSE – SIMPLIFYING LARGE-VOLUME PATCH INJECTIONS
Ian Thompson provides the latest insights into the YpsoDose prefilled and pre-assembled patch injector as it moves into the industrialisation phase for clinical trials.
THE PATH TO COMMERCIALISATION FOR WEARABLE DRUG DELIVERY DEVICES
WEARABLES
Atul Patel
West Pharmaceutical Services
THE PATH TO COMMERCIALISATION FOR WEARABLE DRUG DELIVERY DEVICES
Atul Patel looks at the evolution of the wearable drug delivery market, including the route to commercialisation and the challenges faced.
DESIGNING DRUG DELIVERY DEVICES THROUGH COLLABORATIVE USABILITY TESTING
WEARABLES
Alice Bogrash
Eitan Medical
DESIGNING DRUG DELIVERY DEVICES THROUGH COLLABORATIVE USABILITY TESTING
Alice Bogrash examines how the company uses human factors studies to design drug delivery devices that respond to user needs, while providing a competitive advantage for pharmaceutical companies looking to introduce innovative combination products to the market.
MEETING EMERGING STAKEHOLDER NEEDS WITH THE SUBCUJECT WEARABLE BOLUS INJECTOR
WEARABLES
Tony Bedford
Phillips Medisize
MEETING EMERGING STAKEHOLDER NEEDS WITH THE SUBCUJECT WEARABLE BOLUS INJECTOR
Tony Bedford looks at the emerging market for on-body injectors coupled with stakeholder needs and introduces the Subcuject wearable bolus injector, which is designed to accommodate these requirements.
TACKLING HIGH-VOLUME ADMINISTRATION CHALLENGES WITH A SMART, SUSTAINABLE ON-BODY INJECTOR PLATFORM
WEARABLES
Séverine Duband
Nemera
TACKLING HIGH-VOLUME ADMINISTRATION CHALLENGES WITH A SMART, SUSTAINABLE ON-BODY INJECTOR PLATFORM
Séverine Duband introduces Symbioze, Nemera’s novel on-body injector platform device, comprising a reusable main unit and disposable prefilled drug container, and offering a balance between the need to deliver advanced formulations at high volumes and the desire for patient-centric ease-of-use that enables patients to self-administer their therapies at home.
HIGH PRECISION IN PLASTICS IMPROVES THE QUALITY OF LIFE OF DIABETES PATIENTS
WEARABLES
Steffen Reuter
HIGH PRECISION IN PLASTICS IMPROVES THE QUALITY OF LIFE OF DIABETES PATIENTS
Steffen Reuter discusses the importance of high precision when manufacturing injection moulded components for wearable insulin delivery devices, with particular reference to three such parts from a recent project as a case study for Weidmann Medical Technology’s approach.
USING SIMULATION AND MODELLING VERSUS PROTOTYPING FOR MEDICAL RADIO FREQUENCY DESIGN
EXPERT VIEW
Enrico Denna
USING SIMULATION AND MODELLING VERSUS PROTOTYPING FOR MEDICAL RADIO FREQUENCY DESIGN
Enrico Denna looks at the advantages of a simulation and modelling approach over prototyping for the design of medical products.
COMPLEXITY OF PATCH PUMP ASSEMBLY AND CONSIDERATIONS FOR MASTERING IT
WEARABLES
Roger Nordy
COMPLEXITY OF PATCH PUMP ASSEMBLY AND CONSIDERATIONS FOR MASTERING IT
Roger Nordy discusses the complexities of patch pump assembly and explains how ATS has been mastering the intricacies of the automation process to take on the growing industry demand.
VECTRA<sup>®</sup> MT<sup>®</sup> LCP BRINGS THE ADVANTAGES OF LIQUID CRYSTAL POLYMERS TO WEARABLE INJECTORS
WEARABLES
Wim Vos
Celanese
VECTRA® MT® LCP BRINGS THE ADVANTAGES OF LIQUID CRYSTAL POLYMERS TO WEARABLE INJECTORS
Wim Vos, Dave Pellegrino and Rob Haley discuss the myriad benefits of Vectra® MT® LCP, Celanese’s medical-grade liquid crystal polymer, for wearable injection devices, including improved patient comfort, greater design flexibility and reduced processing costs.
REPOSITIONING FROM IV TO VIAL-BASED SC FOR LARGE-VOLUME BIOLOGICS
WEARABLES
Thomas Mayer
Sonceboz
REPOSITIONING FROM IV TO VIAL-BASED SC FOR LARGE-VOLUME BIOLOGICS
Tom Mayer discusses the growing trend of moving away from intravenous drugs administered in clinical and hospital settings to at-home, self-administered vial-based subcutaneous delivery for cost savings, better lifecycle management and improved care.
OPTIONS FOR ACTIVATION OF BATTERY-OPERATED MEDICAL DEVICES
EXPERT VIEW
Tim Resker
OPTIONS FOR ACTIVATION OF BATTERY-OPERATED MEDICAL DEVICES
Tim Resker looks at new technologies for powering on battery-operated drug delivery devices while considering battery drain, ingress protection and user-friendliness.
EXTENDING CONTAINER CLOSURE INTEGRITY TO WEARABLE INJECTORS
EXPERT VIEW
Shaun Devitt
EXTENDING CONTAINER CLOSURE INTEGRITY TO WEARABLE INJECTORS
Shaun Devitt looks at how the principles and methods of container closure integrity might be adapted for wearable injectors.
DRUG DELIVERY: WHAT DO PATIENTS AND PROVIDERS WANT?
WEARABLES
Matthew Huddleston
Enable Injections
DRUG DELIVERY: WHAT DO PATIENTS AND PROVIDERS WANT?
Matthew Huddleston and Jennifer Estep discuss current drug delivery options and the value of convenient care.
CONNECTED DEVICES CHALLENGE: HOW TO DEVELOP CONCEPT DEVICES WITH PEEK POLYMERS
CONNECTIVITY
Marcus Jarman-Smith
Victrex
CONNECTED DEVICES CHALLENGE: HOW TO DEVELOP CONCEPT DEVICES WITH PEEK POLYMERS
Marcus Jarman-Smith, Adam Salmen, John Devine, Ernst Hupkes and Dennis Freie discuss the value of PEEK, a high-performance polymer, in drug delivery device design, using two concept devices – an on-body patch pump and vaporiser inhaler.
Top